BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 11243648)

  • 1. Serum interleukin-15 levels are not elevated in patients with stage I and II mycosis fungoides.
    Sugaya M; Nakamura K; Tamaki K
    Acta Derm Venereol; 2000; 80(6):455. PubMed ID: 11243648
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum Soluble CD48 Levels as a Prognostic Marker in Mycosis Fungoides and Sézary Syndrome.
    Oka T; Miyagaki T; Takahashi N; Nakajima R; Kamijo H; Suga H; Asano Y; Sugaya M; Sato S
    J Invest Dermatol; 2018 Oct; 138(10):2286-2288. PubMed ID: 29605670
    [No Abstract]   [Full Text] [Related]  

  • 3. Fibrinogen-like Protein 2 Activity as a Potential Biomarker for Diagnosis of Early Mycosis Fungoides.
    Sherman S; Rabizadeh E; Moyal L; Livnat T; Ziv E; Cherny I; Inbal A; Hodak E
    Acta Derm Venereol; 2017 Mar; 97(3):370-372. PubMed ID: 27535237
    [No Abstract]   [Full Text] [Related]  

  • 4. Soluble interleukin-2 receptor serum levels in mycosis fungoides. Correlation with clinical stage.
    Szeimies RM; Rueff F; Kaudewitz P
    Cancer; 1992 Nov; 70(9):2338-41. PubMed ID: 1394062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thymus and activation-regulated chemokine (TARC/CCL17) in mycosis fungoides: serum TARC levels reflect the disease activity of mycosis fungoides.
    Kakinuma T; Sugaya M; Nakamura K; Kaneko F; Wakugawa M; Matsushima K; Tamaki K
    J Am Acad Dermatol; 2003 Jan; 48(1):23-30. PubMed ID: 12522366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased serum neopterin levels in mycosis fungoides and Sézary syndrome.
    Hamerlinck FF; Toonstra J; van Vloten WA
    Br J Dermatol; 1999 Dec; 141(6):1136-7. PubMed ID: 10722267
    [No Abstract]   [Full Text] [Related]  

  • 7. Mycosis fungoides.
    Sterry W
    Curr Top Pathol; 1985; 74():167-223. PubMed ID: 3882347
    [No Abstract]   [Full Text] [Related]  

  • 8. A distinct profile of serum levels of soluble intercellular adhesion molecule-1 and intercellular adhesion molecule-3 in mycosis fungoides and Sézary syndrome.
    López-Lerma I; Estrach MT
    J Am Acad Dermatol; 2009 Aug; 61(2):263-70. PubMed ID: 19615537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum IL-31 levels are increased in patients with cutaneous T-cell lymphoma.
    Ohmatsu H; Sugaya M; Suga H; Morimura S; Miyagaki T; Kai H; Kagami S; Fujita H; Asano Y; Tada Y; Kadono T; Sato S
    Acta Derm Venereol; 2012 May; 92(3):282-3. PubMed ID: 22456907
    [No Abstract]   [Full Text] [Related]  

  • 10. Expression of Sézary Biomarkers in the Blood of Patients with Erythrodermic Mycosis Fungoides.
    Hurabielle C; Michel L; Ram-Wolff C; Battistella M; Jean-Louis F; Beylot-Barry M; d'Incan M; Bensussan A; Bagot M
    J Invest Dermatol; 2016 Jan; 136(1):317-20. PubMed ID: 26763453
    [No Abstract]   [Full Text] [Related]  

  • 11. The Sézary cell in the blood of patients with mycosis fungoides.
    Winkelmann RK; Hoagland HC
    Dermatologica; 1980; 160(2):73-9. PubMed ID: 6965373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folliculotropic mycosis fungoides with extreme pilosebaceous involvement and hematological abnormalities.
    Mizuno-Ikeda K; Hamada T; Suzuki D; Morizane S; Watanabe T; Imada M; Okada K; Iwatsuki K
    Eur J Dermatol; 2014; 24(1):135-6. PubMed ID: 24589554
    [No Abstract]   [Full Text] [Related]  

  • 13. Increased serum level of stem cell factor in association with disease progression of hyperpigmented mycosis fungoides.
    Yamamoto T; Katayama I; Nishioka K
    Br J Dermatol; 1999 Apr; 140(4):765-6. PubMed ID: 10233346
    [No Abstract]   [Full Text] [Related]  

  • 14. Mycosis fungoides with blast cell transformation.
    Harrington CI; Slater DN
    Arch Dermatol; 1978 Apr; 114(4):611-2. PubMed ID: 274101
    [No Abstract]   [Full Text] [Related]  

  • 15. Tumor Stage Mycosis Fungoides in a Child.
    Dulmage BO; Villaseñor-Park J; Ho J; Geskin LJ; Grandinetti LM
    Pediatr Dermatol; 2015; 32(4):e156-8. PubMed ID: 25892093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early-stage mycosis fungoides screening investigations: a retrospective analysis of 440 cases.
    Bawazir MA; Almohideb M; Walsh S; Shear NH; Alhusayen R
    J Eur Acad Dermatol Venereol; 2018 Jun; 32(6):e217-e218. PubMed ID: 29220538
    [No Abstract]   [Full Text] [Related]  

  • 17. High Expression of Fas/CD95 on CD4+ Circulating T Cells: An Exclusion Criterion in the Diagnosis of Mycosis Fungoides?
    Du-Thanh A; Portalès P; Serre-Cousiné A; Girard C; Guillot B; Dereure O
    Acta Derm Venereol; 2017 Jul; 97(7):834-837. PubMed ID: 28206666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoblastic sarcoma with leukemic blood picture in the terminal stage of mycosis fungoides.
    Schwarze EW; Ude P
    Virchows Arch A Pathol Anat Histol; 1975 Dec; 369(2):165-72. PubMed ID: 814706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Normal serum adenosine deaminase activity in mycosis fungoides.
    Yalçin B; Sahin S; Ciliv G
    Acta Derm Venereol; 1997 Sep; 77(5):403-4. PubMed ID: 9298144
    [No Abstract]   [Full Text] [Related]  

  • 20. Increased serum thymic stromal lymphopoietin levels in patients with cutaneous T cell lymphoma.
    Miyagaki T; Sugaya M; Fujita H; Saeki H; Tamaki K
    Clin Exp Dermatol; 2009 Jun; 34(4):539-40. PubMed ID: 19236423
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.